Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Adela Cardones MD, MHSc

Adela Rambi G. Cardones MD, MHSc

Professor and Dermatology Division Chief, University of Kansas Medical Center, Kansas City, Kansas

Disclosures

Dr. Cardones reports that she is a site Principal Investigator for an industry sponsored clinical trial by Octapharma.

Recent Contributions to PracticeUpdate:

  1. Durability of Long-Term Immunomodulating Medications in the Treatment of Patients With Bullous Pemphigoid
  2. A Randomized Double-Blind Trial of Intravenous Immunoglobulin for Bullous Pemphigoid

Most Read This Week

Recently Updated